Variant report

Variant	esv3487948
Chromosome Location	chr4:8581052-8584350
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:152)
CpG islands
(count:793)
Chromatin interactive
region (count:3)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:152 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr4:8582336-8582809	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr4:8582079-8582264	H1-hESC	embryonic stem cell:	n/a	n/a
3	BHLHE40	chr4:8582469-8582507	K562	blood:	n/a	n/a
4	CBX3	chr4:8582339-8582560	K562	blood:	n/a	n/a
5	CBX3	chr4:8582296-8582613	K562	blood:	n/a	n/a
6	CCNT2	chr4:8582433-8582494	K562	blood:	n/a	n/a
7	CEBPB	chr4:8582137-8582518	H1-hESC	embryonic stem cell:	n/a	n/a
8	CEBPB	chr4:8582383-8582545	K562	blood:	n/a	n/a
9	CEBPB	chr4:8582431-8582583	HepG2	liver:	n/a	n/a
10	CHD2	chr4:8581823-8582048	H1-hESC	embryonic stem cell:	n/a	n/a
11	CHD2	chr4:8582278-8582814	H1-hESC	embryonic stem cell:	n/a	n/a
12	CREB1	chr4:8581868-8583002	H1-hESC	embryonic stem cell:	n/a	n/a
13	CTCF	chr4:8582680-8582830	WERI-Rb-1	eye:	n/a	n/a
14	CTCF	chr4:8582438-8582475	Fibrobl	skin:	n/a	n/a
15	CTCF	chr4:8582380-8582530	SAEC	small airway:	n/a	n/a
16	CTCF	chr4:8582380-8582530	HUVEC	blood vessel:	n/a	n/a
17	CTCF	chr4:8582390-8582490	H1-hESC	embryonic stem cell:	n/a	n/a
18	CTCF	chr4:8582480-8582630	AG04449	skin:	n/a	n/a
19	CTCF	chr4:8582340-8582490	SK-N-SH_RA	brain:	n/a	n/a
20	CTCF	chr4:8582400-8582550	Caco-2	colon:	n/a	n/a
21	E2F6	chr4:8581956-8583024	H1-hESC	embryonic stem cell:	n/a	n/a
22	E2F6	chr4:8582063-8583030	H1-hESC	embryonic stem cell:	n/a	n/a
23	ELF1	chr4:8582348-8582624	K562	blood:	n/a	n/a
24	GABPA	chr4:8582270-8582883	H1-hESC	embryonic stem cell:	n/a	n/a
25	GABPA	chr4:8582082-8582950	H1-hESC	embryonic stem cell:	n/a	n/a
26	GTF2F1	chr4:8582599-8582626	H1-hESC	embryonic stem cell:	n/a	n/a
27	HCFC1	chr4:8582361-8582516	K562	blood:	n/a	n/a
28	HDAC2	chr4:8582305-8582893	H1-hESC	embryonic stem cell:	n/a	chr4:8582572-8582580 chr4:8582442-8582461
29	HDAC2	chr4:8582178-8582756	MCF-7	breast:	n/a	chr4:8582572-8582580 chr4:8582442-8582461
30	HMGN3	chr4:8582184-8582640	K562	blood:	n/a	n/a
31	JUN	chr4:8582207-8582209	H1-hESC	embryonic stem cell:	n/a	n/a
32	JUND	chr4:8582348-8582554	H1-hESC	embryonic stem cell:	n/a	n/a
33	JUND	chr4:8582147-8582773	H1-hESC	embryonic stem cell:	n/a	n/a
34	JUND	chr4:8582344-8582562	K562	blood:	n/a	n/a
35	KAP1	chr4:8582411-8582830	HEK293	kidney:	n/a	n/a
36	MAX	chr4:8581889-8582688	MCF-7	breast:	n/a	n/a
37	MAX	chr4:8581906-8583031	H1-hESC	embryonic stem cell:	n/a	n/a
38	MAX	chr4:8582301-8582643	K562	blood:	n/a	n/a
39	MAX	chr4:8582361-8582900	H1-hESC	embryonic stem cell:	n/a	n/a
40	MAX	chr4:8581921-8583042	H1-hESC	embryonic stem cell:	n/a	n/a
41	MAX	chr4:8582306-8582626	K562	blood:	n/a	n/a
42	MAX	chr4:8581977-8582968	ECC-1	luminal epithelium:	n/a	n/a
43	MAX	chr4:8581977-8582964	ECC-1	luminal epithelium:	n/a	n/a
44	MAX	chr4:8582346-8582561	K562	blood:	n/a	n/a
45	MAX	chr4:8582343-8582591	NB4	blood:	n/a	n/a
46	MAZ	chr4:8582293-8582674	K562	blood:	n/a	n/a
47	MAZ	chr4:8582376-8582657	HepG2	liver:	n/a	n/a
48	MAZ	chr4:8582164-8582784	IMR90	lung:	n/a	n/a
49	MXI1	chr4:8582180-8582941	IMR90	lung:	n/a	n/a
50	MXI1	chr4:8582150-8582926	H1-hESC	embryonic stem cell:	n/a	n/a

(count:793 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:8582300-8582350	MCF10A-Er-Src	breast:	n/a
2	chr4:8582565-8582615	Hela-S3	cervix:	n/a
3	chr4:8583363-8583413	T-47D	breast:	n/a
4	chr4:8583363-8583413	PrEC	prostate:	n/a
5	chr4:8583937-8583987	AG09319	gingival:	n/a
6	chr4:8582300-8582350	CMK	blood:	n/a
7	chr4:8582287-8582337	GM06990	blood:	n/a
8	chr4:8581650-8581700	MCF10A-Er-Src	breast:	n/a
9	chr4:8582171-8582221	GM12891	blood:	n/a
10	chr4:8582249-8582299	GM19239	blood:	n/a
11	chr4:8582110-8582160	GM06990	blood:	n/a
12	chr4:8582287-8582337	Hepatocyte	liver:	n/a
13	chr4:8582300-8582350	GM06990	blood:	n/a
14	chr4:8582110-8582160	K562	blood:	n/a
15	chr4:8582249-8582299	AG10803	skin:	n/a
16	chr4:8582287-8582337	A549	lung:	n/a
17	chr4:8582287-8582337	LNCaP	prostate:	n/a
18	chr4:8583937-8583987	AG09309	skin:	n/a
19	chr4:8582287-8582337	PrEC	prostate:	n/a
20	chr4:8583363-8583413	ProgFib	skin:	n/a
21	chr4:8583363-8583413	HRPEpiC	eye:	n/a
22	chr4:8582171-8582221	K562	blood:	n/a
23	chr4:8583363-8583413	A549	lung:	n/a
24	chr4:8581734-8581784	Jurkat	blood:	n/a
25	chr4:8582101-8582151	HRE	kidney:	n/a
26	chr4:8582101-8582151	HNPCEpiC	eye:	n/a
27	chr4:8583363-8583413	HRCEpiC	kidney:	n/a
28	chr4:8582287-8582337	HPAEpiC	pulmonary alveolar:	n/a
29	chr4:8581734-8581784	HMEC	breast:	n/a
30	chr4:8583363-8583413	SK-N-SH_RA	brain:	n/a
31	chr4:8582300-8582350	AoSMC	blood vessel:	n/a
32	chr4:8581650-8581700	GM12878	blood:	n/a
33	chr4:8581650-8581700	PFSK-1	brain:	n/a
34	chr4:8582287-8582337	HRPEpiC	eye:	n/a
35	chr4:8581424-8581474	HCF	heart:	n/a
36	chr4:8582287-8582337	AoSMC	blood vessel:	n/a
37	chr4:8581734-8581784	HCM	heart:	n/a
38	chr4:8582227-8582277	PANC-1	pancreas:	n/a
39	chr4:8582227-8582277	SAEC	small airway:	n/a
40	chr4:8582565-8582615	HCT-116	colon:	n/a
41	chr4:8583363-8583413	K562	blood:	n/a
42	chr4:8582110-8582160	HCM	heart:	n/a
43	chr4:8582287-8582337	GM12878	blood:	n/a
44	chr4:8581734-8581784	HRPEpiC	eye:	n/a
45	chr4:8581650-8581700	AG10803	skin:	n/a
46	chr4:8583937-8583987	NHDF-neo	bronchial:	n/a
47	chr4:8581424-8581474	T-47D	breast:	n/a
48	chr4:8581650-8581700	LNCaP	prostate:	n/a
49	chr4:8582171-8582221	MCF10A-Er-Src	breast:	n/a
50	chr4:8582565-8582615	HAEpiC	amniotic membrane:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:8582157..8584012-chr4:8592733..8594974,2	MCF-7	breast:
2	chr1:7246479..7246979-chr4:8580772..8581329,2	MCF-7	breast:
3	chr4:8506167..8508857-chr4:8582205..8583898,2	MCF-7	breast:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GPR78-1	chr4:8582122-8582438	NONHSAT095110
2	lnc-GPR78-1	chr4:8584258-8584371	NR_045511
3	lnc-GPR78-1	chr4:8582122-8582251	NONHSAT095109
4	lnc-GPR78-1	chr4:8581964-8582431	NR_045511

No data

Variant related genes	Relation type
GPR78	TF binding region
GPR78	CpG island
ENSG00000205959	chromatin interactions
ENSG00000109625	chromatin interactions
GADD45A	miRNA target sites
GABRB3	miRNA target sites

Extended variants
information (count: 234 )
Associated
traits (count: 54 )

Variant overlapped rSNPs/rCNVs (count:234 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs569058573	chr4:8581070-8581071	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs566597832	chr4:8581074-8581075	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs528273095	chr4:8581076-8581077	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs116654200	chr4:8581083-8581084	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs568052990	chr4:8581103-8581104	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs535380291	chr4:8581116-8581117	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs550576767	chr4:8581122-8581123	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs544652235	chr4:8581156-8581157	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs562843176	chr4:8581157-8581158	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs190486048	chr4:8581165-8581166	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs557912106	chr4:8581240-8581241	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs572929824	chr4:8581300-8581301	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs534405556	chr4:8581307-8581308	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs113740795	chr4:8581314-8581315	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs2270268	chr4:8581336-8581337	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs187681296	chr4:8581357-8581358	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs79597549	chr4:8581369-8581370	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs562936355	chr4:8581419-8581420	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs6817637	chr4:8581420-8581421	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs6817643	chr4:8581425-8581426	Bivalent Enhancer Enhancers Weak transcription	CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs191713630	chr4:8581445-8581446	Bivalent Enhancer Enhancers Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
22	rs527769060	chr4:8581470-8581471	Bivalent Enhancer Enhancers Weak transcription	CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs546433428	chr4:8581477-8581478	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs376103281	chr4:8581501-8581502	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs80313651	chr4:8581505-8581506	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs561522397	chr4:8581523-8581524	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs529218234	chr4:8581533-8581534	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs550618901	chr4:8581544-8581545	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs569109151	chr4:8581567-8581568	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs539067621	chr4:8581639-8581640	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs370471901	chr4:8581650-8581651	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs116402051	chr4:8581684-8581685	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs28424132	chr4:8581710-8581711	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs533871916	chr4:8581719-8581720	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs556024726	chr4:8581722-8581723	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs574136750	chr4:8581732-8581733	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs184915493	chr4:8581733-8581734	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs372211541	chr4:8581742-8581743	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
39	rs116252123	chr4:8581774-8581775	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
40	rs533334492	chr4:8581872-8581873	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs146109297	chr4:8581873-8581874	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs373600301	chr4:8581876-8581877	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs140574429	chr4:8581886-8581887	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs149721941	chr4:8581948-8581949	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs187742325	chr4:8581951-8581952	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs145541357	chr4:8581955-8581956	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs371023078	chr4:8581967-8581968	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
48	rs375620455	chr4:8581985-8581986	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
49	rs529101203	chr4:8581988-8581989	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
50	rs550574111	chr4:8581995-8581996	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:54)

Disease	PMID	Source
Melanoma	20688739	CNVD
Wilms tumour	21544195	CNVD
Colorectal cancer	16272173	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17603634	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21785460	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Breast cancer	21509527	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Schizophrenia	22241247	CNVD
Autosomal-dominant microtia	18179897	CNVD
Glioma	17123091	CNVD
Colorectal cancer	20459617	CNVD
Breast cancer	17133270	CNVD
Sezary syndrome	18413736	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Schizophrenia	21346763	CNVD

Chromatin state (count:135 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:8573400-8609400	Weak transcription	Right Atrium	heart
2	chr4:8574400-8582400	Weak transcription	Placenta Amnion	Placenta Amnion
3	chr4:8577600-8581400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr4:8577600-8582000	Weak transcription	Ovary	ovary
5	chr4:8578600-8581800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
6	chr4:8578600-8582200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
7	chr4:8580000-8581200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
8	chr4:8580000-8581200	Weak transcription	H9 Cell Line	embryonic stem cell
9	chr4:8580000-8581600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
10	chr4:8580600-8581400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr4:8580800-8582200	Enhancers	Placenta	Placenta
12	chr4:8581000-8581400	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
13	chr4:8581000-8581400	Bivalent Enhancer	HSMMtube	muscle
14	chr4:8581000-8581600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
15	chr4:8581000-8581600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
16	chr4:8581200-8581400	Enhancers	H9 Cell Line	embryonic stem cell
17	chr4:8581200-8581400	Bivalent Enhancer	Right Ventricle	heart
18	chr4:8581200-8581600	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
19	chr4:8581200-8581600	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
20	chr4:8581200-8581600	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
21	chr4:8581200-8581600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
22	chr4:8581200-8582200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
23	chr4:8581400-8581600	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
24	chr4:8581400-8581800	Weak transcription	H9 Cell Line	embryonic stem cell
25	chr4:8581400-8581800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
26	chr4:8581400-8581800	Enhancers	HUES48 Cell Line	embryonic stem cell
27	chr4:8581400-8582000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr4:8581400-8582200	Bivalent Enhancer	Fetal Muscle Leg	muscle
29	chr4:8581400-8582800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
30	chr4:8581400-8583000	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
31	chr4:8581600-8581800	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
32	chr4:8581600-8581800	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
33	chr4:8581600-8581800	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
34	chr4:8581600-8581800	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
35	chr4:8581600-8581800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
36	chr4:8581600-8581800	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
37	chr4:8581600-8582000	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
38	chr4:8581600-8582000	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
39	chr4:8581600-8582200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
40	chr4:8581600-8582400	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
41	chr4:8581600-8582800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
42	chr4:8581600-8582800	Enhancers	Esophagus	oesophagus
43	chr4:8581600-8583200	Enhancers	Pancreas	Pancrea
44	chr4:8581800-8582000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
45	chr4:8581800-8582000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
46	chr4:8581800-8582600	Active TSS	H1 Cell Line	embryonic stem cell
47	chr4:8581800-8582600	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
48	chr4:8581800-8582600	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
49	chr4:8581800-8582800	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
50	chr4:8581800-8583000	Active TSS	H9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links